Articles and posts This page contains articles and posts from 2018 to 2024. USelectAllNewsPresentationsArticlesAcquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letterSeptember 15, 2022 | News, Non regulatoryNeola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of SeptemberSeptember 12, 2022 | News, Non regulatoryNeola Medical AB: Notice of extraordinary general meeting in Neola Medical ABSeptember 8, 2022 | News, Non regulatoryThe board of directors of Neola Medical has resolved on a rights issue of approximately SEK 55 million subject to approval by an Extraordinary General MeetingSeptember 8, 2022 | News, RegulatoryNeola Medical at the UENPS congress 2022September 6, 2022 | NewsDo not miss BioStock’s latest article about Neola Medical with CEO Hanna SjöströmSeptember 1, 2022 | NewsClinical Manager recruited – Neola Medical strengthens the team with a neonatologistSeptember 1, 2022 | News, Non regulatoryCEO Hanna Sjöström at The Future of Swedish & Danish Life Science 7th of SeptemberAugust 25, 2022 | NewsCEO and CFO presents Q2 report for 2022August 17, 2022 | News, PresentationsHör CEO Hanna Sjöström i rapportkommentar i Nyhetsbyrån DirektAugust 16, 2022 | News, PresentationsQ2 report 2022- a quarter with big commercial steps forwardAugust 16, 2022 | Articles, News, RegulatoryNeola Medical bjuder in till presentation av Q2-rapport 2022August 10, 2022 | News, Press release# 1234567891011121314151617181920212223242526272829 $ Subscribe For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Acquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letterSeptember 15, 2022 | News, Non regulatory
Neola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of SeptemberSeptember 12, 2022 | News, Non regulatory
Neola Medical AB: Notice of extraordinary general meeting in Neola Medical ABSeptember 8, 2022 | News, Non regulatory
The board of directors of Neola Medical has resolved on a rights issue of approximately SEK 55 million subject to approval by an Extraordinary General MeetingSeptember 8, 2022 | News, Regulatory
Do not miss BioStock’s latest article about Neola Medical with CEO Hanna SjöströmSeptember 1, 2022 | News
Clinical Manager recruited – Neola Medical strengthens the team with a neonatologistSeptember 1, 2022 | News, Non regulatory
CEO Hanna Sjöström at The Future of Swedish & Danish Life Science 7th of SeptemberAugust 25, 2022 | News
Q2 report 2022- a quarter with big commercial steps forwardAugust 16, 2022 | Articles, News, Regulatory